Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
The New England Journal of Medicine|May 6, 1999
Infliximab for the treatment of fistulas in patients with Crohn's diseaseD H Present, P Rutgeerts, S Targan, et al.The Mount Sinai Journal of Medicine, New York|November 1, 2001
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamineG Haralambou, A S Teirstein, J Gil, et al.The American Journal of Gastroenterology|October 1, 1991
Maintenance oral sulfasalazine prolongs remission in ulcerative proctitis and proctosigmoiditisD LaRosa, P H Rubin, C Bodian, et al.Gastroenterology|October 1, 1988
Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acidR Pamukcu, S B Hanauer, E B ChangThe American Journal of Gastroenterology|June 11, 1999
Intravenous cyclosporin in ulcerative colitis: a five-year experienceR D Cohen, R Stein, S B HanauerThe American Journal of Gastroenterology|October 15, 1998
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence studyS V Kane, K Sable, S B HanauerAlimentary Pharmacology & Therapeutics|May 15, 2004
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteersW J Sandborn, S B Hanauer, A BuchScandinavian Journal of Gastroenterology. Supplement|January 1, 1988
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trialS Meyers, D B Sachar, D H Present, et al.Gastroenterology|December 1, 1987
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trialS Meyers, D B Sachar, D H Present, et al.DICP : the Annals of Pharmacotherapy|December 1, 1989
Medical management of inflammatory bowel diseaseR F Sottile, C M Quandt, D H Present, et al.Pageof 16